Use parathyroid hormone to fight brittle bone disease
A study conducted on more than 1600 women reveals that parathyroid hormone (parathormone) increases the patient’s bone density and cut the risk of fractures in them. The same hormone is also useful in regulating calcium levels in the body. The new aspect of the hormone guarding aga...Businessman Exposed Problems With Quest Subsidiary's Blood Test Kits; Led to $302 Million Settlement
...ialysis patients at risk. As a result of the faulty tests, the lawsuit said, some dialysis patients underwent unnecessary surgery to remove their parathyroid and were administered unnecessary treatment that can cause a painful, deadly disease. Today's settlement covers claims that the bad tests led to overt...AACE/AIUM develop physician certification and accreditation in thyroid/parathyroid ultrasound
...edicine (AIUM) have been working together to improve the quality of diagnostic ultrasound and ultrasound-guided invasive procedures of the thyroid and parathyroid glands. The quality of care depends in part on the knowledge and experience of the physician who performs and/or interprets the examination. With ...Arab-American women need supplement to boost dangerously low vitamin D levels
...ion of fortified milk or fortified orange juice and vitamin supplements. Blood samples also were taken onsite and analyzed for levels of vitamin D and parathyroid hormone and other minerals. Dr. Hobbs says Henry Ford is launching an awareness campaign to educate the Arab American community in Dearborn about t...Dilon Technologies' Slant15(TM) and LEHR Collimators Enhance Imaging Capabilities
... Uses include: breast imaging; sentinel node imaging; thyroid imaging; and parathyroid imaging. LEHR collimator is a high-resolution collimator for general nuclear medicine applications. Uses include thyroid imaging, parathyroid imaging, sentinel node imaging, spot bone imaging, gall bladder ejection, a...Michigan Pre-Seed Capital Fund Invests in Three More Michigan Start-Ups
...r diagnostic test and a lung cancer prognostic test. -- Aursos, sponsored by the Kalamazoo SmartZone, received $200,000. Aursos specializes in parathyroid hormone (PTH) treatments for osteoporosis that increase bone formation and decrease bone degradation. To date, 25 additional seed-stage compan...Study identifies causes of bone loss in breast cancer survivors
...ssive calcium excretion in urine and an overactive parathyroid gland. "Doctors evaluating breast cancer patien...cancer patients. And in 5 percent of patients, the parathyroid gland was overactive, producing a hormone that cau...re, Camacho said. There are various treatments for parathyroid gland disorder, depending on its cause. In ce...High-normal phosphate levels linked to early atherosclerosis
...experimental, it cannot establish any cause-and-effect relationship. In addition, it lacked data on some possibly relevant laboratory valuesespecially parathyroid hormone and vitamin D, which, like phosphate, have important effects on bone. ...VAI Finding Could Lead to New Drugs for Anxiety, Depression
... to form salt crystals but much more difficult. The lab used a unique method to do this that they recently developed to determine the structure of the parathyroid hormone (PTH) receptor, used to treat osteoporosis. PTH and CRF receptors are in the same family of proteins. "There are many therapeutically import...Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
...s -- Satiety and oral glucose challenge studies for both GLP-1 and PYY will be undertaken later this year at University Hospital, Switzerland -- parathyroid hormone continues on a progressive clinical development path in collaboration with Novartis Pharma AG Emisphere has 11 products in preclinical d...Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
...of the United States -- A food-intake study for both GLP-1 and PYY will be undertaken later this year at University Hospital, Switzerland -- parathyroid hormone continues on a progressive clinical development path in collaboration with Novaris Pharma AG Emisphere has 11 products in preclinical de...Emisphere Technologies, Inc. Reports Clinical Data on Oral Delivery of GLP-1 and PYY
... macromolecules and charged organics. Emisphere and its partners have advanced oral formulations or prototypes of salmon calcitonin, heparin, insulin, parathyroid hormone, human growth hormone and cromolyn sodium into clinical trials. Emisphere has strategic alliances with world-leading pharmaceutical companies....Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
...rine calcium, serum ionized calcium and serum phosphorus. No drug-related adverse events were reported. Significant reduction in the blood levels of parathyroid hormone (PTH) was observed in this trial, suggesting that CTA018 has potential as a treatment for secondary hyperparathyroidism in chronic kidney dise...Intact PTH EIA Bone and Mineral Metabolism 021-SDX016 Parathyroid Hormone
Description: Intact PTH EIA Bone and Mineral Metabolism 021-SDX016 Parathyroid Hormone...U-M scientist to talk about tissue engineering at AAAS
...ed therapies to improve the benefits of tissue engineering. For example, parathyroid hormone is given to patients with osteoporosis, a condition in which bone quality declines leaving them fragile and prone to breaking. parathyroid hormone stimulates bone growth in these patients, and Krebsbach sees potent...Zosano Pharma, Inc. Announces Appointment of Gail Schulze as Chair and CEO
...tives to advance the company's novel therapeutic programs, including its lead product Zosano PTH Patch, a proprietary transdermal patch formulation of parathyroid hormone (PTH) for the treatment of established osteoporosis. "Gail brings a tremendous track record of executive leadership to Zosano, and her depth...Global Study Reveals Differences in Standard of Care for Osteoporosis Across the World
...racture index score of less than or equal to 5, according to Black et al(v). Bone medications included bishosphonates, raloxifene, strontium ranelate, parathyroid hormone (1-84), teriparatide, tibolone, and calcitonin. GLOW is being conducted by The Center for Outcomes Research (COR), University of Massachuset...Emisphere Technologies, Inc. Announces 2008 First Quarter Financial Results
...ral glucose challenge studies for both GLP-1 and PYY were started in humans with data expected during the second quarter of this year; and -- parathyroid hormone and human growth hormone are in development in collaboration with Novartis Pharma AG Emisphere conducts a variety of preclinical researc...Emisphere Technologies, Inc. Announces 2007 Fourth Quarter and Year End Financial Results
...and oral glucose challenge studies for both GLP-1 and PYY were started in humans with data expected during the second quarter of this year -- parathyroid Hormone and Recombinant Human Growth Hormone continue on a development path in collaboration with Novartis Pharma AG Emisphere conducts a variet...Stonegate Report About Unigene Laboratories Inc.
...tion of peptides and patented technologies for the oral and nasal delivery of peptides. The Company has also licensed the worldwide rights to its oral parathyroid (PTH) technology to GlaxoSmithKline (NYSE: GSK ) and the worldwide rights for its calcitonin manufacturing technology to Novartis Pharma AG (NYSE: N...NPS Pharmaceuticals to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
...g two late-stage programs: GATTEX(TM) (teduglutide) is in Phase 3 clinical development for intestinal failure associated with short bowel syndrome and parathyroid hormone 1-84 [rDNA origin] injection is in Phase 2 clinical development as a hormone therapy for hypoparathyroidism. NPS has also completed a Phase 3 ...NPS Pharmaceuticals Announces Senior Management Changes
...g two late-stage programs: GATTEX(TM) (teduglutide) is in Phase 3 clinical development for intestinal failure associated with short bowel syndrome and parathyroid hormone 1-84 [rDNA origin] injection is in Phase 2 clinical development as a hormone therapy for hypoparathyroidism (parathyroid hormone 1-84 [rDNA or...Nastech Announces Third Quarter 2007 Financial Results
...7 was $1.9 million, compared to $5.5 million for the quarter ended September 30, 2006. The 2006 period included revenue of $4.8 million related to our parathyroid Hormone (PTH1-34) nasal spray collaboration with Procter & Gamble Pharmaceuticals, Inc. ("P&G"). Revenue for the nine months ended September 30, 2007 ...NPS Pharmaceuticals Announces Approval of Cinacalcet HCl in Japan
...se on dialysis. It regulates the over-secretion of parathyroid hormone (PTH) in patients with chronic kidney insufficiency by acting directly on the parathyroid gland calcium-sensing receptor. Elevated levels of...ent of elevated levels of calcium in patients with parathyroid carcinoma. NPS president and CEO Dr. Tony Coles s...Rabbit Anti-Human Parathyroid Hormone Receptor 2 Polyclonal Antibody, Unconjugated from Abcam
Description: Rabbit polyclonal to Parathyroid Hormone Receptor 2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: AFRHCNPNGTWDFMHSLN, corresponding to extracellular amino acids 99-116 of Human Parathyroid Hormone Receptor 2 Entrez Gene ID: 5746 Swiss Protein ID: P49190...